Vanta Holdings closes first private placement tranche and announces director resignation

Vanta Holdings Inc., a consumer health sciences and longevity company, has closed the first tranche of a previously announced non-brokered private placement. The company issued 124,579 units at $1.00 per unit, generating gross proceeds of $124,579.42.

Each unit consists of one common share and one transferable common share purchase warrant. The warrants allow holders to acquire an additional share at an exercise price of $1.25 until August 21, 2028. The securities are subject to a statutory hold period ending December 22, 2026.

In a separate development, Vanta reported that Norman John Campbell resigned from the board of directors, effective August 21, 2026. This resignation leaves the board with four members, consisting of two independent and two non-independent directors.

The private placement remains ongoing, with the company expecting to close remaining portions in one or more additional tranches on or before October 5, 2026, subject to Canadian Securities Exchange policies.